Skip to main content

Innosuisse — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

213
Companies
$612.4M
Total invested
$3.1M
Avg. check
51
Industries
Health Care 7Software 5Medical Device 5Manufacturing 5Artificial Intelligence (AI) 4Medical 4+45 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 213
Bionomous
September 2024

Bionomous automates the screening, sorting, and plating of miniature biological entities to accelerating science

Biotechnology · Villaz-saint-pierre$3.5M Debt Financing
Pelt8
September 2024

Pelt8 is a software company developing a cloud-based data collection platform, multiple reporting standards, and audit trails.

Cloud Management · ZürichSeed
Deegtal
September 2025

Deegtal is a technology company that provides solutions to enhance the efficiency and accuracy of epilepsy diagnosis.

Artificial Intelligence (AI) · Geneva$809K Grant
Pulsewave
September 2022

Discreet and reliable remote patient monitoring with existing eyeglasses

Eyewear · Biel$120K Pre-Seed
REOR20
September 2025

SaaS, pre-event high fidelity flood risk assessment, post-event accurate flood analysis

Insurance · ZürichGrant
EDWATEC
September 2025

EDWATEC is at the forefront of developing Erbium-doped photonic integrated circuits for optical amplification on-chip.

Optical Communication · LausanneGrant
csky.ai
September 2025

csky.ai specializes in using Edge AI technologies to enrich even the most sensitive discussions.

Artificial Intelligence (AI) · PrillyGrant
Calvin Risk
September 2025

Calvin Risk develops comprehensive and quantitative solutions to assess and manage the risks of AI algorithms in commercial use.

Artificial Intelligence (AI) · KlotenGrant
qCella
September 2025

qCella Impregnate natural fibers with copper and utilize them to create heating mats that outperform commercially available heating wires.

Manufacturing · ZürichGrant
Fabas
September 2025

Fabas is an e-commerce website that offers food products like hummus, bean burgers, and falafel made from locally grown Swiss legumes.

E-Commerce · SchlierenGrant
Hemetron
September 2025

Hemetron offers a handheld blood testing device that measures biomarkers for at‑home health monitoring and remote result sharing.

Health Care · ZürichGrant
Apheros
September 2025

Apheros is a metal foam cooling solutions company that offers a patent-pending easily scalable manufacturing approach for metal foams.

3D Printing · ZürichGrant
INERGIO
September 2025

INERGIO is a reliable power power supply yet is a challenge to off-grid systems.

Environmental Consulting · LausanneGrant
HeroSupport
September 2025

HeroSupport transforms imaging and/or treatment tables into personalized solutions.

Health Care · VeyrierGrant
Oxara
September 2025

Oxara is a construction technology company that manufactures low carbon, circular, and healthy building materials for real estate projects.

Association · DietikonGrant
Planeto
September 2025

Planeto is an energy transition company that engages in the design of sustainable district heating and cooling networks in buildings.

Energy · Plan-les-ouatesGrant
AMF Medical
September 2022

AMF Medical is a MedTech company that develops an Insulin Patch Pump.

Diabetes · Ecublens$8.2M Corporate Round
Typewise
August 2023

AI Customer Service Platform for Enterprises

Artificial Intelligence (AI) · ZürichNon-equity Assistance
RocketVax
August 2021

RocketVax is a biotech company that develops novel vaccines by incorporating molecular and DNA-based technology.

Biotechnology · Basel$4.4M Seed
Zaphiro Technologies
August 2023

Zaphiro has developed a real-time monitoring and automation system that enhances the efficiency and profitability of grid operations.

Internet of Things · EcublensGrant
Vandria
August 2024

Vandria creates mitophagy inducers that renew cells to address ageing and chronic disorders.

Manufacturing · Lausanne$10.1M Series A
Mabylon
August 2025

Mabylon develops novel antibody therapeutics in immunology & inflammation (I&I) and neurological disorders.

Biotechnology · Schlieren$18.6M Undisclosed
Librec
August 2021

Librec provides technology for “closed-loop” recycling of large lithium-ion batteries from e-mobility.

Battery · Oensingen$2.8M Seed
InnoSpina
August 2022

At InnoSpina, we design and develop novel 3d printed implants and unique surgical guiding instruments to treat back pain in less than 30min

Health Care · Courroux$631K Pre-Seed

Where Innosuisse invests

Health Care7
Software5
Medical Device5
Manufacturing5
Artificial Intelligence (AI)4
Medical4

About Innosuisse's portfolio

How many companies has Innosuisse invested in?

Innosuisse has invested in 213 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Innosuisse invest in?

Innosuisse's top investment sectors include Health Care, Software, Medical Device, Manufacturing, Artificial Intelligence (AI). The firm invests across 51 different industry categories.

What is Innosuisse's largest investment?

Among tracked funding rounds, Mabylon received $18.6M in a Undisclosed round. Innosuisse's total known invested capital is $612.4M.

What is the average investment size for Innosuisse?

Innosuisse's average investment size is $3.1M across its portfolio of 213 companies.

What are Innosuisse's most recent investments?

Recent Innosuisse portfolio additions include Bionomous, Pelt8, Deegtal, Pulsewave, REOR20. These companies were founded in 2020 or later.

Reach the founders behind these 213 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →